echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > In December, collen reported again that 2 billion varieties passed the consistency evaluation!

    In December, collen reported again that 2 billion varieties passed the consistency evaluation!

    • Last Update: 2018-12-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On December 13, the amoxicillin capsule of Kelun Pharmaceutical Co., Ltd passed the consistency evaluation According to the announcement issued by Kelun Pharmaceutical Co., Ltd., Kelun Pharmaceutical Co., Ltd has invested about 7.36 million yuan in the consistency evaluation project of amoxicillin capsule Data source: drug registration and acceptance database drug details drug name: amoxicillin capsule dosage form: capsule specification: 0.25g (calculated according to c16h19n3o5s) application items: domestic drug registration conformity evaluation registration classification: chemical applicant: Hunan Kelun Pharmaceutical Co., Ltd Approval conclusion: after review, amoxicillin capsule is a class a medical insurance drug through the consistency evaluation of quality and efficacy of generic drugs, and has been included in the national basic drug catalog in 2018 According to the Kelun announcement, amoxicillin capsule's sales volume in China in 2017 was about 2.059 billion yuan In addition, amoxicillin capsule (0.25g, 0.125g) is a 289 drug At present, domestic enterprises declare it very hot According to the data of pharmaceutical intelligence, the drug is the one with the most application acceptance numbers At present, there are 26 acceptance numbers and 19 enterprises declare it The passage of amoxicillin capsule is shown in the following table: data source: amoxicillin capsule, a database for registration and acceptance of intellectual drugs, is mainly used for infectious diseases in adults and children caused by sensitive bacteria (strains that do not produce β lactamase) Amoxicillin is a broad-spectrum β - lactam antibiotic of penicillin It has strong antibacterial and bactericidal effects on most of the pathogenic Gram-positive and Gram-negative bacteria It is widely used in the treatment of upper respiratory tract infection, urogenital tract infection, skin and soft tissue infection, lower respiratory tract infection caused by sensitive bacteria and in combination with other drugs to eradicate Helicobacter pylori, and it is light and medium There is no need to adjust the dosage in patients with DN It is widely recommended by authoritative guidelines and consensus such as diagnosis and treatment of adult community acquired pneumonia in China (2016 Edition) and guidelines for clinical application of antibiotics (2015 Edition) Data source of application for conformity assessment of Kelun: Declaration of drug registration and acceptance database: the viewpoint of this article only represents the author, not the position of drug intelligence network, and welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.